Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole

Neth J Med. 2010 Oct;68(10):329-30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / administration & dosage*
  • Aged
  • Anti-Ulcer Agents / administration & dosage*
  • Anti-Ulcer Agents / adverse effects
  • Famotidine / administration & dosage*
  • Histamine H2 Antagonists / administration & dosage
  • Humans
  • Magnesium Deficiency / blood
  • Magnesium Deficiency / chemically induced*
  • Magnesium Deficiency / drug therapy
  • Male
  • Omeprazole / adverse effects*
  • Pantoprazole
  • Proton Pump Inhibitors / administration & dosage
  • Proton Pump Inhibitors / adverse effects*
  • Treatment Outcome

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Histamine H2 Antagonists
  • Proton Pump Inhibitors
  • Famotidine
  • Pantoprazole
  • Omeprazole